跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 140 条关于
“TRKB”
全部
140
临床试验
57
药物
67
机构
4
资讯
12
3天前
Kasvu Therapeutics Raises €30M to Advance Non-Hallucinogenic TrkB-Targeting Depression Drug KTX-0141
上个月
Micot Pharma's MT200605 Hits Phase II Primary Endpoint in Acute Ischemic Stroke, Offering First-in-Class Multi-Stage Neuroprotection
上个月
NexTel Medical to Acquire Xycota Biosciences, Gaining Exosome-Delivered Neuro-Restoration Platform with Pending FDA Orphan Drug Designation
4个月前
Weill Cornell Researchers Reverse Engineer Ketamine's Antidepressant Mechanism, Paving Way for Safer Alternatives
前天
XtalPi Files FDA IND for KQTD-126, a Gut-Restricted pan-TRK Inhibitor for IBS and IBD Pain
去年
CONNECTA Therapeutics Advances First-in-Class Neuroplasticity Modulator CTH120 to Phase II for Pediatric Fragile X Syndrome
去年
Larotrectinib Shows High Efficacy in Pediatric Solid Tumors with NTRK Fusion
去年
Next-Generation TRK Inhibitors Show Promise in Treating NTRK Fusion-Positive Cancers
去年
TRexBio Secures $84 Million in Series B Funding to Advance TNFR2 Agonist TRB-061
去年
TRexBio Initiates First-in-Human Trial of TRB-061, Novel TNFR2 Agonist for Atopic Dermatitis
第 1 页,共 2 页
上一页
下一页